tirzepatide for breastfeeding Ozempic® or Mounjaro® and Breastfeeding: Safety Evidence does tirzepatide pass through breast
Description
Most patients begin noticing weight loss within the first four to eight weeks of starting tirzepatide dosing for weight loss in units
Meanwhile, Mounjaro uses dual activity for potentially stronger appetite and glucose control
Participants in the trial first were given meal replacement with ultra-low-calorie diets for eight weeks, and those who lost 5% of their body weight (about 90% of those recruited) were randomized to four groups
This was a retrospective study, not a randomized controlled trial
Early outcomes depend on dosage, eating habits, and exercise
